Search This Blog

Thursday, February 27, 2020

Concert Pharma EPS misses by $0.07

Concert Pharma (NASDAQ:CNCE): Q4 GAAP EPS of -$0.86 misses by $0.07.
Revenue of $0.01M (flat Y/Y)
https://seekingalpha.com/news/3546349-concert-pharma-eps-misses-0_07

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.